Arginine

Arginine

SCHEMBL10654400

C[C@H](NC(=S)SCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O.N=C(N)NCCC[C@H](N)C(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ ACE known ✓ P12821 13/20 0.46
▸ LMNA P02545 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ACE2 Q9BYF1 4/20 0.38
▸ EPHA2 P29317 1/20 0.38
▸ BDKRB2 P30411 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL10654662 0.87 ACE (0.43) ACELMNASMN1; SMN2ACE2
Arginine SCHEMBL10653944 0.87 ACE (0.51) ACELMNASMN1; SMN2
Arginine SCHEMBL10653999 0.86 PREP (0.51) ACELMNASMN1; SMN2ACE2
SCHEMBL10657882 0.86 ACE (0.54) ACELMNASMN1; SMN2ACE2
Arginine SCHEMBL10656209 0.85 ACE (0.44) ACELMNASMN1; SMN2ACE2
Arginine SCHEMBL10866875 0.84 ACE (0.40) ACELMNAACE2
Arginine SCHEMBL10658646 0.84 ACE (0.47) ACELMNASMN1; SMN2
Arginine SCHEMBL7263661 0.84 ACE (0.47) ACELMNASMN1; SMN2
Arginine SCHEMBL7264429 0.84 ACE (0.47) ACELMNASMN1; SMN2
SCHEMBL30974453 0.80 ACE (0.40) ACELMNAACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4719200-A Amino acid derivatives and antihypertensive drugs containing the same AJINOMOTO CO., INC. (JP) 1988-01-12 — — US disclosed
EP-0173510-A2 Tripeptide derivatives for use as anti-hypertensive agents AJINOMOTO CO., INC. (JP) 1986-03-05 — — EP disclosed
Send feedback